Eckert & Ziegler SE (XTER:EUZ) Short Interest


XTER:EUZ Eckert & Ziegler SE XTER:EUZ
98 GF Score
Price €15.41
GF Value €16.25
Valuation Fairly Valued
View Full Analysis

What is Eckert & Ziegler SE Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTER:EUZ vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Eckert & Ziegler SE's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eckert & Ziegler SE Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Short Interest distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Short Interest falls into.


XTER:EUZ
98GF Score
Eckert & Ziegler SE XTER:EUZ
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?

Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued. The current stock price of €15.41 is trading 5.2% below its estimated GF Value™ of €16.25. GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.

Key valuation signals for XTER:EUZ:

  • Short Interest:
  • GF Value™: €16.25 vs. price of €15.41 (5.2% below fair value)
  • GF Score™: 98/100

No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eckert & Ziegler SE Business Description

Address Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score

Get the complete analysis for XTER:EUZ

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.41
Price
€16.25
GF Value